Is signet-ring cell carcinoma a specific entity among gastric cancers?
Fiche publication
Date publication
octobre 2016
Journal
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
Auteurs
Membres identifiés du Cancéropôle Est :
Pr BRIGAND Cécile
Tous les auteurs :
Voron T, Messager M, Duhamel A, Lefevre J, Mabrut JY, Goere D, Meunier B, Brigand C, Hamy A, Glehen O, Mariette C, Paye F
Lien Pubmed
Résumé
The prognosis and chemoresistance of signet-ring cell (SRC) gastric adenocarcinoma have been reported and debated, and the utility of perioperative chemotherapy for such a tumor has been questioned . This study was performed to assess the impact of the SRC type on survival following resection of gastric adenocarcinoma, and to assess whether the prognostic factors (including perioperative chemotherapy) for non-SRC adenocarcinoma differed from those for SRC adenocarcinoma.
Mots clés
Chemotherapy, Gastric adenocarcinoma, Prognosis, Signet-ring cell, Surgery
Référence
Gastric Cancer. 2016 Oct;19(4):1027-1040